Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acids, encompassing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), are the primary molecules responsible for the storage, transmission, and expression of genetic information in all living organisms. DNA is predominantly located in the nucleus, where it serves as the permanent template for life, while various forms of RNA operate in both the nucleus and cytoplasm to translate genetic codes into functional proteins and regulate cellular processes [1][3]. In pharmacology, these molecules are critical therapeutic targets; for instance, traditional chemotherapies like alkylating agents and intercalators directly damage DNA to induce apoptosis in rapidly dividing cancer cells [4]. More recently, the therapeutic landscape has expanded to include RNA-targeted therapies, such as antisense oligonucleotides and siRNA, which selectively modulate the expression of disease-associated proteins [2]. While highly effective, targeting nucleic acids poses significant challenges, including the risk of non-specific genomic damage and the potential for long-term mutagenic effects [5]. Sources: [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175321/ [2] https://www.nature.com/articles/nrd.2017.101 [3] https://www.uniprot.org/keywords/KW-0540 [4] https://www.cancer.gov/about-cancer/treatment/types/chemotherapy [5] https://pubmed.ncbi.nlm.nih.gov/21531079/
Drugs interact with nucleic acids through various mechanisms including covalent cross-linking (alkylation), intercalation between base pairs, inhibition of synthesis via antimetabolites, induction of strand breaks through topoisomerase inhibition, and sequence-specific binding via antisense oligonucleotides or RNA interference (RNAi) to modulate translation or degradation [1][2].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic acid (DNA and RNA) (DNA/RNA).